REFERENCES
- Fiala C. Medical abortion: where we are in Europe. Entre Nous 2000;47–8:16–17
- Registratienieuws. Gebu prikbord 1999;33;113
- WHO. Medical Methods for Termination of Pregnancy. Technical Report Series 871. Geneva: World Health Organization, 1997
- Aubeny E. Medical abortion – early reports. Entre Nous 1994;26–7:11–12
- Aubeny E, Peyron R, Turpin C, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopause Stud 1995: 40(Suppl 2): 85–91
- Aubeny E. Methods of abortion in Europe during the first trimester of pregnancy. Eur J Contracept Reprod Health Care 1997;2:75–80
- Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med 2000;342:946–56
- Kahn JG, Becker BJ, Maclsaa L, et al. The efficacy of medical abortion. A meta-analysis. Contraception 2000; 61:29–40
- Trussel J, Ellertson C. Estimating the efficacy of medical abortion. Contraception 1999;60:119–35
- Peyron R, Aubeny E, Targosz V, et al. Early termina- tion of pregnancy with mifepristone and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328:1509–13
- Safar P, Fiala C. Schwangerschafstabbruch mit Mifepriston und Misoprostol in Österreich. Erste Erfahrungen. Frauenarzt 2000;41:325–30
- Silvestre L, Dubois C, Renault M, et al. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. N Engl J Med 1990;322:645–53
- Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2 or 3 days after mife- pristone for early medical abortion. J Am Med Assoc 2000;284:1948–53
- Urquhart D, Templeton A, Shinewi F, et al. The effi- cacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation, UK multicentric study – final results. Contraception 1997;55:1–5
- Spitz IM, Bardin WC, Benton L, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241–7
- Rademakers J. Abortus in Nederland 1991–1992. Utrecht: Stimezo Nederland, 1995
- Luteijn F, Hamel LF, Bouwman TK, et al. HSCL Hopkins Symptom Checklist, handleiding. Lisse: Swets & Zeitlinger, 1984
- Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1977
- Glasier A, Thong KJ, Dewar M, et al. Mifepristone (RU 486) compared with high-dose estrogen and progesto- gen for emergency postcoital contraception. N Engl J Med 1992;327:1041–4
- Ashok PW, Wagaarachchi PT, Flett GM, et al. Mife- pristone as a late post-coital contraceptive. Hum Reprod 2001;16:72–5
- WHO Task Force on Postovulatory Methods of Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a random- ised trial. Lancet 1999;353:697–702